FIELD: medicine, oncosurgery.
SUBSTANCE: on removing the affected lobe of thyroid gland with isthmus it is necessary to make a longitudinal cut along resection line of the rest healthy lobe of thyroid gland. This cut should be urgently sent for histological trial, at detecting the complexes of cancer cells in the cut it is important to fulfill radical operation, the removal of the rest lobe of thyroid gland. In case of no tumor cells and macroscopic pathological alterations along resection line it is necessary to carry out revision and suture in the surgical wound. The innovation enables to choose the volume of surgical interference and decrease the number of post-surgical complications.
EFFECT: higher efficiency and accuracy of detection.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF THYROID GLAND MALIGNANT TUMORS IN CHILDREN AND ADOLESCENT | 2005 |
|
RU2300106C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING THYROID GLAND NODULAR NEOPLASMS IN CHILDREN AND ADOLESCENT CASES | 2004 |
|
RU2285923C2 |
| METHOD FOR PREDICTING MALIGNANT THYROID TUMORS | 2003 |
|
RU2229262C1 |
| METHOD OF ESTIMATION OF ANGIOGENIC FACTORS AT CHEMOTHERAPY OF CANCER OF MAMMARY GLAND | 2006 |
|
RU2341198C2 |
| METHOD FOR PREOPERATIVE DETERMINATION OF VOLUME OF SURGICAL TREATMENT OF HIGH-DIFFERENTIATED THYROID CANCER | 2018 |
|
RU2709140C1 |
| METHOD OF EVALUATING EFFICIENCY OF INTRAMURAL AUTOPLASMOCHEMICAL THERAPY OF URINE BLADDER CANCER | 2009 |
|
RU2398517C1 |
| METHOD FOR DETERMINATION OF MALIGNANT PROCESS ABUNDANCE | 2005 |
|
RU2289815C1 |
| METHOD OF LAPAROSCOPIC ORGAN-PRESERVING TREATMENT OF INVASIVE CERVICAL CANCER | 2017 |
|
RU2652069C2 |
| METHOD FOR DETERMINING AUTOHEMOCHEMOTHERAPY EFFECTIVENESS IN TREATING THE CASES OF CARCINOMA AFFECTING RECTOSIGMOID PORTION OF THE RECTUM AND SIGMOID COLON AND AUTOHEMOCHEMOTHERAPY COMBINED WITH ULTRAHIGH FREQUENCY HYPERTHERMIA IN TREATING THE CASES OF RECTAL CARCINOMA | 2001 |
|
RU2219553C2 |
| METHOD OF CONSERVATION THERAPY OF INVASIVE CERVICAL CANCER | 2017 |
|
RU2661077C1 |
